Literature DB >> 6299277

A new unextracted-sample radioimmunoassay method for hepatic endogenous nuclear L-tri-iodothyronine content. Validity of its use in determining nuclear receptor binding characteristics.

T Yagura, P G Walfish.   

Abstract

Endogenous l-tri-iodothyronine content in an hepatic nuclear extract was measured by a new unextracted-sample radioimmunoassay method using 8-anilinonaphthalene-1-sulphonic acid to inhibit the l-[(125)I]tri-iodothyronine binding to the nuclear l-tri-iodothyronine receptor within the extract. For this method, the lower sensitivity limit was 3.125 pg/tube, the recovery of added l-tri-iodothyronine was 90-120%, and the between-assay coefficient of variation was 10%. The amount of endogenous l-tri-iodothyronine was 10-40 pg/0.2 ml of hepatic nuclear extract from euthyroid rats, compared with less than 3.125 pg/0.2 ml from thyroidectomized rats. The results obtained by this new method were compared with a Sephadex G-25 column extracted-sample radioimmunoassay method and showed a good agreement. The values for the endogenous l-tri-iodothyronine content were utilized to correct for the l-tri-iodothyronine concentration within the binding assay mixture in order to accurately determine by Scatchard analysis the binding characteristics of the nuclear l-tri-iodothyronine receptor. The validity of the correction for endogeneous l-tri-iodothyronine was demonstrated by using a nuclear extract from a thyroidectomized rat which was preincubated with a small known amount of l-tri-iodothyronine before determining the nuclear l-tri-iodothyronine receptor binding characteristics. When the Scatchard plots were corrected for the preincubated dose, the results obtained were similar to true values, but they were falsely lower when not corrected. It is concluded that the necessity and validity of using endogenous l-tri-iodothyronine corrections in the Scatchard analytical computations of the nuclear l-tri-iodothyronine receptor binding characteristics has been demonstrated, being particularly more important for affinity constant than maximum binding capacity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299277      PMCID: PMC1154013          DOI: 10.1042/bj2080641

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Thyroid hormone action. Demonstration of similar receptors in isolated nuclei of rat liver and cultured GH1 cells.

Authors:  H H Samuels; J S Tsai
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  Specific nuclear triiodothyronine binding sites in rat liver and kidney.

Authors:  J H Oppenheimer; D Koerner; H L Schwartz; M I Surks
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

3.  Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  Endocrinology       Date:  1974-09       Impact factor: 4.736

4.  In vitro triiodothyronine binding to non-histone proteins from rat liver nuclei.

Authors:  P Thomopoulos; B Dastugue; N Defer
Journal:  Biochem Biophys Res Commun       Date:  1974-05-20       Impact factor: 3.575

5.  In vitro demonstration of specific triiodothyronine binding sites in rat liver nuclei.

Authors:  D Koerner; M I Surks; J H Oppenheimer
Journal:  J Clin Endocrinol Metab       Date:  1974-04       Impact factor: 5.958

6.  Limited capacity binding sites for L-triiodothyronine in rat liver nuclei. Localization to the chromatin and partial characterization of the L-triiodothyronine-chromatin complex.

Authors:  M I Surks; D Koerner; W Dillman; J H Oppenheimer
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

7.  Limitations in the conventional analysis of the interaction of triiodothyronine with solubilized nuclear receptor sites. Inapparent binding of triiodothyronine to nonspecific binding sites.

Authors:  S Seelig; H L Schwartz; J H Oppenheimer
Journal:  J Biol Chem       Date:  1981-03-10       Impact factor: 5.157

8.  An improved radioimmunoassay of triiodothyronine in serum: its application to clinical and physiological studies.

Authors:  I J Chopra; R S Ho; R Lam
Journal:  J Lab Clin Med       Date:  1972-11

9.  Thyroid hormone action in cell culture: domonstration of nuclear receptors in intact cells and isolated nuclei.

Authors:  H H Samuels; J S Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

10.  Limited binding capacity sites for L-triiodothyronine in rat liver nuclei. Nuclear-cytoplasmic interrelation, binding constants, and cross-reactivity with L-thyroxine.

Authors:  J H Oppenheimer; H L Schwartz; D Koerner; M I Surks
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.